Therefore, in this study, we aimed to assess PD-1, PD-L1, PD-L2 mRNA expression before-after primary systemic therapy (chemotherapy and hormonal therapy) using real-time PCR and investigate the association with clinicopathological features and overall survival of advanced breast cancer patients. Here, PDCD1LG2 is linked to breast cancer.